PL354263A1 - Sposób wytwarzania preparatu o przedłużonym uwalniSposób wytwarzania preparatu o przedłużonym uwalnianiuaniu - Google Patents

Sposób wytwarzania preparatu o przedłużonym uwalniSposób wytwarzania preparatu o przedłużonym uwalnianiuaniu

Info

Publication number
PL354263A1
PL354263A1 PL00354263A PL35426300A PL354263A1 PL 354263 A1 PL354263 A1 PL 354263A1 PL 00354263 A PL00354263 A PL 00354263A PL 35426300 A PL35426300 A PL 35426300A PL 354263 A1 PL354263 A1 PL 354263A1
Authority
PL
Poland
Prior art keywords
make
sustained release
release formulation
formulation
sustained
Prior art date
Application number
PL00354263A
Other languages
English (en)
Other versions
PL199862B1 (pl
Inventor
Thomas CiaranLoughman Thomas Ciaran Loughman
Original Assignee
Kinerton Limitedkinerton Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kinerton Limitedkinerton Limited filed Critical Kinerton Limitedkinerton Limited
Publication of PL354263A1 publication Critical patent/PL354263A1/pl
Publication of PL199862B1 publication Critical patent/PL199862B1/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6927Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a solid microparticle having no hollow or gas-filled cores
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/593Polyesters, e.g. PLGA or polylactide-co-glycolide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Biological Depolymerization Polymers (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Peptides Or Proteins (AREA)
PL354263A 1999-08-18 2000-08-14 Sposób wytwarzania kompleksu o przedłużonym uwalnianiu i sposób wytwarzania mikrocząstek tego kompleksu PL199862B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE19990700A IES990700A2 (en) 1999-08-18 1999-08-18 Process to make a sustained release formulation
PCT/IE2000/000099 WO2001012232A2 (en) 1999-08-18 2000-08-14 Process to make a sustained release formulation

Publications (2)

Publication Number Publication Date
PL354263A1 true PL354263A1 (pl) 2003-12-29
PL199862B1 PL199862B1 (pl) 2008-11-28

Family

ID=11042112

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354263A PL199862B1 (pl) 1999-08-18 2000-08-14 Sposób wytwarzania kompleksu o przedłużonym uwalnianiu i sposób wytwarzania mikrocząstek tego kompleksu

Country Status (26)

Country Link
US (1) US6893645B1 (pl)
EP (1) EP1212095B1 (pl)
JP (1) JP3730917B2 (pl)
CN (2) CN1246040C (pl)
AR (1) AR022647A1 (pl)
AT (1) ATE243044T1 (pl)
AU (1) AU755229B2 (pl)
BR (1) BR0013349A (pl)
CA (1) CA2380902C (pl)
CZ (1) CZ294433B6 (pl)
DE (1) DE60003438T2 (pl)
DK (1) DK1212095T3 (pl)
ES (1) ES2195925T3 (pl)
HK (1) HK1044285A1 (pl)
HU (1) HUP0202895A3 (pl)
IE (1) IES990700A2 (pl)
IL (1) IL148044A0 (pl)
MX (1) MXPA02001415A (pl)
NO (1) NO20020762L (pl)
NZ (1) NZ517251A (pl)
PL (1) PL199862B1 (pl)
PT (1) PT1212095E (pl)
RU (1) RU2211694C1 (pl)
TW (1) TWI230069B (pl)
WO (1) WO2001012232A2 (pl)
ZA (1) ZA200202027B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE252915T1 (de) * 1999-08-18 2003-11-15 Sod Conseils Rech Applic Formulierung zur verzögerten freisetzung von peptiden
US7109166B1 (en) 1999-08-18 2006-09-19 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Sustained release formulation of a peptide
EP1348444B1 (en) * 1999-08-18 2006-04-12 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Sustained release formulation of a peptide complexed with a polymer
WO2005061088A1 (en) * 2003-12-22 2005-07-07 Finlay Warren H Powder formation by atmospheric spray-freeze drying
MX2007004676A (es) 2004-10-27 2007-11-14 Univ Denver Analogos de la hormona adrenocorticotropica y metodos relacionados.

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863985A (en) * 1995-06-29 1999-01-26 Kinerton Limited Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
US6221958B1 (en) * 1993-01-06 2001-04-24 Societe De Conseils De Recherches Et D'applications Scientifiques, Sas Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides
DK0678018T3 (da) * 1993-01-06 2003-04-28 Kinerton Ltd Ion molekylærkonjugater af bionedbrydelige polyestere og bioaktive polypeptider
UA44707C2 (uk) * 1993-08-09 2002-03-15 Біомежер, Інк. Похідні пептидів та спосіб лікування раку
IE960308A1 (en) 1996-04-23 1997-11-05 Kinerton Ltd Sustained release ionic conjugate
AU3215597A (en) * 1996-08-30 1998-03-19 Biomeasure Incorporated Method of inhibiting fibrosis with a somatostatin agonist
US5972893A (en) * 1997-05-06 1999-10-26 Cedars-Sinai Medical Center Method of treating hyperprolactinemia and prolactinomas
PL342135A1 (en) * 1998-01-29 2001-05-21 Kinerton Ltd Method of obtaining absorbable microparticle
US6568407B1 (en) 1998-08-28 2003-05-27 Mitutoyo Corporation Automatic washing device for a workpiece to be measured and automatic production system provided with the same
ATE252915T1 (de) * 1999-08-18 2003-11-15 Sod Conseils Rech Applic Formulierung zur verzögerten freisetzung von peptiden

Also Published As

Publication number Publication date
CZ294433B6 (cs) 2005-01-12
IES990700A2 (en) 2001-08-22
ZA200202027B (en) 2002-12-24
EP1212095B1 (en) 2003-06-18
DK1212095T3 (da) 2003-10-06
RU2002106809A (ru) 2004-01-20
HUP0202895A3 (en) 2003-11-28
NO20020762L (no) 2002-04-16
RU2211694C1 (ru) 2003-09-10
JP2003507346A (ja) 2003-02-25
CN1823736A (zh) 2006-08-30
NZ517251A (en) 2003-08-29
NO20020762D0 (no) 2002-02-15
PT1212095E (pt) 2003-10-31
PL199862B1 (pl) 2008-11-28
CZ2002266A3 (cs) 2002-05-15
CA2380902C (en) 2008-08-05
ES2195925T3 (es) 2003-12-16
DE60003438T2 (de) 2004-05-06
CA2380902A1 (en) 2001-02-22
WO2001012232A2 (en) 2001-02-22
DE60003438D1 (de) 2003-07-24
MXPA02001415A (es) 2002-08-12
IL148044A0 (en) 2002-09-12
US6893645B1 (en) 2005-05-17
WO2001012232A3 (en) 2002-04-04
EP1212095A2 (en) 2002-06-12
CN1377283A (zh) 2002-10-30
ATE243044T1 (de) 2003-07-15
CN1246040C (zh) 2006-03-22
AU755229B2 (en) 2002-12-05
JP3730917B2 (ja) 2006-01-05
AR022647A1 (es) 2002-09-04
HK1044285A1 (en) 2002-10-18
AU6464700A (en) 2001-03-13
TWI230069B (en) 2005-04-01
BR0013349A (pt) 2002-04-23
WO2001012232A8 (en) 2002-06-06
HUP0202895A2 (hu) 2003-02-28

Similar Documents

Publication Publication Date Title
PL349428A1 (en) Detergent tablets
EP1247258A4 (en) SOFTWARE BASE STAMP DISTRIBUTOR
IL147802A0 (en) Sustained release formulation of a peptide
HK1047274A1 (zh) 氨基苯甲酸衍生物
GB9901349D0 (en) A process
IL148044A0 (en) Process to make a sustained release formulation
AU7887400A (en) A slow release pharmaceutical composition
GB9918087D0 (en) Detergent tablets
GB9925417D0 (en) Improvements relating to screenboxes
SI1212095T1 (en) Process to make a sustained release formulation
GB9902557D0 (en) Improvements to improve a danbouy
SG87119A1 (en) A method to form uniform silicide features
GB0021992D0 (en) A fur remover
AU2950900A (en) Arrangement related to a call procedure
GB9916754D0 (en) A composition
EP1236736A4 (en) 2-AMINOPURINDERIVATE
SI1149089T1 (en) PROCESS TO PREPARE TETRAHYDROTHIOPYRAN-o-FLUORINATED CARBAMATES
GB9926227D0 (en) Garments designed to adhere to similar garments
TW435423U (en) Pacifier used as a decoration
GB2345464B (en) Improvements relating to forms
GB9923835D0 (en) A oval facecloth mated to a sponge
GB9903159D0 (en) Improvements relating to window-walls
GB9929121D0 (en) Improvements relating to buckles
GB9902568D0 (en) Improvements relating to buckles
GB9906228D0 (en) One to a million

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20090814